BRIEF-Abivax Announces Acceptance Of Phase 3 Induction Trials

Sept 29 (Reuters) – Abivax SA: * ABIVAX ANNOUNCES ACCEPTANCE OF ADDITIONAL LATE-BREAKING ABSTRACT FROM THE ABTECT PHASE 3 INDUCTION TRIALS TO BE PRESENTED AT 2025 UNITED EUROPEAN GASTROENTEROLOGY (UEG) MEETING Source text: Further company coverage: ;))

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)